Buy Daclakem : Daclatasvir 60 mg Tablet 28’S Online

Description

1. Composition:

• Daclatasvir: Daclakem tablets contain daclatasvir as the active pharmaceutical ingredient. Daclatasvir is a potent antiviral medication belonging to the class of direct-acting antivirals (DAAs). It is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. Daclatasvir inhibits the action of the HCV nonstructural protein 5A (NS5A), which is essential for viral replication and assembly, thereby preventing the spread of the virus within the body.

2. Indications:

• Hepatitis C Virus (HCV) Infection: Daclakem is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adult patients. It is used in combination with other antiviral medications to achieve sustained virologic response (SVR), which is considered a cure for HCV infection.

3. Dosage and Administration:

• The recommended dosage of Daclakem for the treatment of chronic HCV infection is usually one tablet (60 mg) taken orally once daily.
• Daclakem tablets can be taken with or without food.
• The duration of treatment and specific combination therapy regimen may vary depending on factors such as the genotype of the HCV virus, the patient’s prior treatment history, and the presence of liver cirrhosis.

4. Effectiveness:

• Daclakem has been shown to be highly effective in achieving sustained virologic response (SVR) in patients with chronic HCV infection, regardless of genotype.
• Clinical studies have demonstrated high rates of viral clearance and improvement in liver function markers with the use of daclatasvir-based regimens.

5. Safety Profile:

• Daclakem is generally well-tolerated when used as prescribed. Common side effects may include fatigue, headache, nausea, diarrhea, and insomnia.
• Serious side effects such as hepatotoxicity and bradycardia may occur but are rare.
• Patients should be monitored regularly for liver function tests and cardiac function during treatment.

6. Contraindications:

• Daclakem is contraindicated in patients with a known hypersensitivity to daclatasvir or any of the excipients in the formulation.
• It should not be used in patients with severe liver impairment or in combination with certain medications that may interact with daclatasvir.

7. Precautions:

• Daclakem should be used with caution in patients with a history of cardiovascular disease, as well as in pregnant or breastfeeding women.
• It should be avoided in patients with decompensated liver cirrhosis or severe renal impairment.

8. Storage:

• Daclakem tablets should be stored at room temperature (15°C to 30°C) in a dry place, away from moisture and heat.
• Keep the medication out of reach of children and pets.

Daclakem tablets, containing daclatasvir as the active ingredient, provide a highly effective and well-tolerated treatment option for patients with chronic hepatitis C virus (HCV) infection. Treatment should be initiated and supervised by a qualified healthcare professional, and patients should be closely monitored for both efficacy and safety throughout the treatment course.